臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"wu s g"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 126-150 / 224 (共9頁)
<< < 1 2 3 4 5 6 7 8 9 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2020-07-21T06:09:14Z	Survival of lung adenocarcinoma patients with malignant pleural effusion	Wu S.-G.;Yu C.-J.;Tsai M.-F.;Wei-Yu Liao;Yang C.-H.;Jan I.-S.;Yang P.-C.;Shih J.-Y.; Wu S.-G.; Yu C.-J.; Tsai M.-F.; WEI-YU LIAO; Yang C.-H.; Jan I.-S.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2020-06-30T08:10:09Z	Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor	Chang T.-H. ;Tsai M.-F. ;Kang-Yi Su ;Wu S.-G. ;Huang C.-P. ;Yu S.-L. ;Yu Y.-L. ;Lan C.-C. ;Yang C.-H. ;Lin S.-B. ;Wu C.-P. ;Shih J.-Y. ;Yang P.-C.; Chang T.-H.; Tsai M.-F.; KANG-YI SU; Wu S.-G.; Huang C.-P.; Yu S.-L.; Yu Y.-L.; Lan C.-C.; Yang C.-H.; Lin S.-B.; Wu C.-P.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2020-06-17T03:01:51Z	Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor	Chang T.-H. ;Tsai M.-F. ;Su K.-Y. ;Wu S.-G. ;Huang C.-P. ;Sung-Liang Yu ;Yu Y.-L. ;Lan C.-C. ;Yang C.-H. ;Lin S.-B. ;Wu C.-P. ;Shih J.-Y. ;Yang P.-C.; Chang T.-H.; Tsai M.-F.; Su K.-Y.; Wu S.-G.; Huang C.-P.; SUNG-LIANG YU; Yu Y.-L.; Lan C.-C.; Yang C.-H.; Lin S.-B.; Wu C.-P.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2020-06-17T03:01:31Z	Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C	Chang T.-H.;Tsai M.-F.;Gow C.-H.;Wu S.-G.;Liu Y.-N.;Chang Y.-L.;Sung-Liang Yu;Tsai H.-C.;Lin S.-W.;Chen Y.-W.;Kuo P.-Y.;Yang P.-C.;Shih J.-Y.; Chang T.-H.; Tsai M.-F.; Gow C.-H.; Wu S.-G.; Liu Y.-N.; Chang Y.-L.; SUNG-LIANG YU; Tsai H.-C.; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2020-05-26T09:27:23Z	Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response	Yang P.-C.;Shin J.-Y;Yu C.-J;Chang Y.-L;Gow C.-H;Chih-Hsin Yang;Wu S.-G;Wu J.-Y; Wu J.-Y; Wu S.-G; CHIH-HSIN YANG; Gow C.-H; Chang Y.-L; Yu C.-J; Shin J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:22Z	Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma	Shih J.-Y; Lee Y.-C; Yang P.-C.; Yang P.-C.;Lee Y.-C;Shih J.-Y;Hsu Y.-C;Chih-Hsin Yang;Chang Y.-L;Yu C.-J;Gow C.-H;Wu S.-G; Wu S.-G; Gow C.-H; Yu C.-J; Chang Y.-L; CHIH-HSIN YANG; Hsu Y.-C
臺大學術典藏	2020-05-26T09:27:21Z	First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer	Yang P.-C.;Shih J.-Y;Wei P.-F;Hsu Y.-C;Chang Y.-C;Gow C.-H;Chiu Y.-H;Wu S.-G;Chih-Hsin Yang;Yu C.-J;Wu J.-Y; Wu J.-Y; Yu C.-J; CHIH-HSIN YANG; Wu S.-G; Chiu Y.-H; Gow C.-H; Chang Y.-C; Hsu Y.-C; Wei P.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:21Z	Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern	Yang P.-C.;Shih J.-Y;Tsai M.-F;Yu C.-J;Chih-Hsin Yang;Wu J.-Y;Hsu Y.-C;Chang Y.-L;Wu S.-G; Wu S.-G; Chang Y.-L; Hsu Y.-C; Wu J.-Y; CHIH-HSIN YANG; Yu C.-J; Tsai M.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:13Z	Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations	Wu J.-Y;Wu S.-G;Chih-Hsin Yang;Chang Y.-L;Chang Y.-C;Hsu Y.-C;Shih J.-Y;Yang P.-C.; Wu J.-Y; Wu S.-G; CHIH-HSIN YANG; Chang Y.-L; Chang Y.-C; Hsu Y.-C; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:12Z	Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations	CHIH-HSIN YANG; Yu C.-J; Lee J.-H; Hsu Y.-C; Chang Y.-L; Shih J.-Y; Yang P.-C.; Wu S.-G;Chih-Hsin Yang;Yu C.-J;Lee J.-H;Hsu Y.-C;Chang Y.-L;Shih J.-Y;Yang P.-C.; Wu S.-G
臺大學術典藏	2020-05-26T09:27:10Z	EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR	Yang P.-C.;Chih-Hsin Yang;Yu C.-J;Tsai M.-F;Chen Y.-H;Shih J.-Y;Chang Y.-L;Kuo Y.-W;Wu S.-G; Wu S.-G; Kuo Y.-W; Chang Y.-L; Shih J.-Y; Chen Y.-H; Tsai M.-F; Yu C.-J; CHIH-HSIN YANG; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:07Z	Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR	Yang P.-C.;Shih J.-Y;Wei P.-F;Yu C.-J;Chih-Hsin Yang;Wu J.-Y;Wu S.-G;Chung K.-P; Chung K.-P; Wu S.-G; Wu J.-Y; CHIH-HSIN YANG; Yu C.-J; Wei P.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:03Z	Survival of lung adenocarcinoma patients with malignant pleural effusion	Wu S.-G;Yu C.-J;Tsai M.-F;Liao W.-Y;Chih-Hsin Yang;Jan I.-S;Yang P.-C;Shih J.-Y.; Wu S.-G; Yu C.-J; Tsai M.-F; Liao W.-Y; CHIH-HSIN YANG; Jan I.-S; Yang P.-C; Shih J.-Y.
臺大學術典藏	2020-05-26T09:26:59Z	Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations	Chen Y.-F;Hsieh M.-S;Wu S.-G;Chang Y.-L;Shih J.-Y;Liu Y.-N;Tsai M.-F;Tsai T.-H;Yu C.-J;Chih-Hsin Yang;Yang P.-C.; Chen Y.-F; Hsieh M.-S; Wu S.-G; Chang Y.-L; Shih J.-Y; Liu Y.-N; Tsai M.-F; Tsai T.-H; Yu C.-J; CHIH-HSIN YANG; Yang P.-C.
臺大學術典藏	2020-05-26T09:26:57Z	Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer	Yang P.-C.; Shih J.-Y; Wu S.-G; Yu C.-J; CHIH-HSIN YANG; Wang Y.-F; Lin Y.-T; Lin Y.-T;Wang Y.-F;Chih-Hsin Yang;Yu C.-J;Wu S.-G;Shih J.-Y;Yang P.-C.
臺大學術典藏	2020-05-26T09:26:56Z	IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer	Shih J.-Y.;Chih-Hsin Yang;Yu S.-L;Chen H.-Y;Tsai T.-H;Wu S.-G;Tsai M.-F;Chang T.-H;Liu Y.-N; Liu Y.-N; Chang T.-H; Tsai M.-F; Wu S.-G; Tsai T.-H; Chen H.-Y; Yu S.-L; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏	2020-05-26T09:26:53Z	Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion	Shih J.-Y.;Chih-Hsin Yang;Yu C.-J;Hsieh M.-S;Wu S.-G;Tsai T.-H; Tsai T.-H; Wu S.-G; Hsieh M.-S; Yu C.-J; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏	2020-05-26T09:26:50Z	Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations	Shih J.-Y.;Yang P.-C;Chih-Hsin Yang;Yu C.-J;Chang Y.-L;Wu S.-G;Hsieh M.-S;Chen Y.-F; Chen Y.-F; Hsieh M.-S; Wu S.-G; Chang Y.-L; Yu C.-J; CHIH-HSIN YANG; Yang P.-C; Shih J.-Y.
臺大學術典藏	2020-05-26T09:26:48Z	The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients	Shih J.-Y.;Wen Y.-F;Chih-Hsin Yang;Yang P.-C;Yu C.-J;Chang Y.-L;Tsai M.-F;Liu Y.-N;Wu S-G; Wu S-G; Liu Y.-N; Tsai M.-F; Chang Y.-L; Yu C.-J; Yang P.-C; CHIH-HSIN YANG; Wen Y.-F; Shih J.-Y.
臺大學術典藏	2020-05-26T09:26:37Z	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non?�Small-cell Lung Cancer	Shih J.-Y.;Chih-Hsin Yang;Wu S.-G;Liu Y.-N;Lin Y.-T; Lin Y.-T; Liu Y.-N; Wu S.-G; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏	2020-05-26T09:26:26Z	Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion	Shih J.-Y.;Chih-Hsin Yang;Yu C.-J;Liu Y.-N;Wu S.-G; Wu S.-G; Liu Y.-N; Yu C.-J; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏	2020-05-25T06:51:56Z	Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas	Wu P.-F;Huang W.-C;Yang J.C.-H;Yen-Shen Lu;Shih J.-Y;Wu S.-G;Lin C.-H;Cheng A.-L.; Wu P.-F; Huang W.-C; Yang J.C.-H; YEN-SHEN LU; Shih J.-Y; Wu S.-G; Lin C.-H; Cheng A.-L.
臺大學術典藏	2020-05-25T01:33:01Z	Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer	YEN-TING LIN; Wang Y.-F.; Yang J.C.-H.; Yu C.-J.; Wu S.-G.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2020-05-25T01:32:59Z	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non–Small-cell Lung Cancer	YEN-TING LIN; Liu Y.-N.; Wu S.-G.; Yang J.C.-H.; Shih J.-Y.
臺大學術典藏	2020-05-25T01:32:56Z	Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer	Shih J.-Y.;Yu C.-J.;Liu Y.-N.;Wu S.-G.;Tsai T.-H.;YEN-TING LIN; YEN-TING LIN; Tsai T.-H.; Wu S.-G.; Liu Y.-N.; Yu C.-J.; Shih J.-Y.

顯示項目 126-150 / 224 (共9頁)
<< < 1 2 3 4 5 6 7 8 9 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 51348063 線上人數 : 705 教育部委託研究計畫計畫執行:國立臺灣大學圖書館